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Abstract
Purpose: There is a significant association between insulin resistance and low cardiorespiratory
fitness in nondiabetic subjects. In a population with risk factors for type 2 diabetes (T2DM), before
they are insulin resistant, we investigated low exercise capacity (VO2max) as an early marker of
impaired insulin sensitivity in order to determine earlier interventions to prevent development of
insulin resistance syndrome (IRS) and T2DM.
Methods: Cross-sectional analyses of data on 369 (78 men and 291 women) people at risk for IRS
and T2DM, aged 45.6 +/- 10 years (20-65 years) old from the Community Diabetes Prevention
Project in Minnesota were carried out. The cardiorespiratory fitness (VO2max) by respiratory gas
exchange and bicycle ergometer were measured in our at risk non insulin resistant population and
compared with a control group living in the same geographic area. Both groups were equally
sedentary, matched for age, gender and BMI.
Results: The most prevalent abnormality in the study population was markedly low VO2max when
compared with general work site screening control group, (n = 177; 137F; 40 M, mean age 40 ± 11
years; BMI = 27.8 ± 6.1 kg/m2). Individuals at risk for IRS and T2DM had a VO2max (22 ± 6 ml/kg/
min) 15% lower than the control group VO2max (26 ± 9 ml/kg/min) (p < 0.001). It was foun that
VO2max was inversely correlated with HOMA-IR (r = -0.30, p < 0.0001).
Conclusions: Decreased VO2max is correlated with impaired insulin sensitivity and was the most
prevalent abnormality in a population at risk for IRS and T2DM but without overt disease. This
raises the possibility that decreased VO2 max is among the earliest indicators of IRS and T2DM
therefore, an important risk factor for disease progression.
Introduction
The global prevalence of diabetes in 2009 among adults ≥
20 years of age is estimated to be 171 million. This figure
is 11% higher than the previous estimate [1] and the pro-
jection for year 2030 maybe considerably higher than the
current estimate[2]. Diabetes is a devastating and costly
public health problem. In addition to the serious impact
on quality of life, diabetes can lead to accelerated arterial
Published: 21 September 2009
Diabetology & Metabolic Syndrome 2009, 1:8 doi:10.1186/1758-5996-1-8
Received: 22 March 2009
Accepted: 21 September 2009
This article is available from: http://www.dmsjournal.com/content/1/1/8
© 2009 Leite et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 6
(page number not for citation purposes)
Diabetology & Metabolic Syndrome 2009, 1:8 http://www.dmsjournal.com/content/1/1/8aging and potentially decreased life expectancy. Endothe-
lial dysfunction is a key abnormality found in insulin-
resistance states and vascular dysfunction [3]. Exercise
capacity (VO2max) is strongly correlated with insulin sen-
sitivity [4] and endothelial dysfunction [5].
Traditional and nontraditional cardiovascular (CVD) risk
factors associated with metabolic syndrome are present
long before the onset of clinical diabetes, which raises the
question about their usefulness in assessing risk of devel-
oping diabetes and CVD [6]. Increasing evidence that
interventions involving changes in diet and physical activ-
ity or pharmacological treatment can prevent/delay type 2
diabetes provides an impetus for wider implementation
of preventive approaches [7]. An early marker for insulin
resistance syndrome and diabetes may identify individu-
als in whom earlier interventions may improve arterial
stiffness before significant endothelial dysfunction.
As part of the Community Diabetes Prevention Project
(CDPP) obesity, HbA1c, fasting insulin level, LDL-choles-
terol, HDL-cholesterol, triglyceride, HOMA-IR, fasting
plasma glucose, microalbumin, waist/hip ratio and
VO2max were investigated as early markers of impaired
glucose regulation. This study included individuals who
were at risk for T2DM but who had not yet developed the
full blown insulin resistance syndrome (hypertension,
hyperinsulinemia, obesity, IGT, and dyslipidemia) or
T2DM at baseline.
Methods
Study Population
To identify those at risk for eventually developing IRS
and/or T2DM, a risk assessment tool was developed [8-
11]. The assessment tool includes questions from the
American Diabetes Association diabetes screening ques-
tionnaire [12] (family history of diabetes, more than 20%
over maximum ideal weights, history of diabetes during
pregnancy or having a baby over 9 pounds, sedentary life-
style) and additional questions related to IRS (hyperten-
sion, dyslipidemia and race/ethnicity). This risk
assessment tool was distributed to the community
through the mail, clinics, hospital and pharmacies, and
through local television and public radio by request.
Subjects were included if they met the following criteria:
age 20 to 65 years and family history of diabetes or history
of gestational diabetes, and/or presence of one to three
risk factors for T2DM (obesity, hypertension, dyslipi-
demia) but without all the major components of IRS. Sub-
jects were excluded if they reported having no risk factors
or either limited exercise alone or only racial/ethnicity
alone as the only risk factor, or had a severe medical con-
dition that would make it unlikely that they could per-
form an exercise evaluation or complete the five-year
study. In addition those who were found to have type 2
diabetes and fasting blood glucose > = 110, were excluded
from this cross-section analysis.
The control group was Highsmith employees matched for
age, gender, level of activity and BMI, whose VO2 max was
measured with same Cardio2 Bike protocol as part of
annually health assessment (table 1).
Analysis of oxygen consumption (VO2max)
Cardiorespiratory fitness was measured directly from res-
piratory gas exchange during a maximal, symptom-lim-
ited exercise tolerance test on a bicycle ergometer
(Cardio2 Bike from Medgraphics, St Paul, MN). The
resulting VO2max value in ml of O2 per kg per minute
allows a direct comparison of individuals regardless of
body weight. Individuals' scores are categorized by age
(grouped by decade) and gender as either healthy, moder-
ate risk or high risk [13].
Physical and Laboratory assessment
Physical assessment evaluated height and weight (for cal-
culation of Body Mass Index), waist/hip ratio, blood pres-
sure (sitting), and fitness level (VO2max). For all subjects
fasting plasma glucose was measured and those with FPG
≥ 110 received a 75 g OGTT. In addition, HbA1c (assay
standardized according to DCCT trial), lipid fractionation
(total cholesterol, HDL-cholesterol, triglycerides and cal-
culated LDL-cholesterol), serum fasting insulin levels,
serum C-peptide and microalbumin were obtained.
The calculation of HOMA [14] was performed with the
following formula:
Statistical Analysis
The "Student t-test of significance" and "One-way Analy-
sis of Variance (ANOVA)"was used to test differences of
VO2max between CDPP group with external control
group, being performed at the 0,05 level of significance.
( )
[ ( / ) (
HOMA-IR
Fasting Insulin U ml Fasting Plasma Glucose m
=
×μ mol l/ )]
.22 5
Table 1: Characteristics of external comparison group and 
people at risk for type 2 diabetes and/or IRS (CDPP)
VARIABLE CONTROL CDPP group
N 177 369
Age (years) 40 ± 11 45.7 ± 10
Gender (females/males) 137/40 291/78
BMI (kg/m2) 27.8 ± 6.1 28.8 ± 6.3Page 2 of 6
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and females.
To determine the association of VO2max levels and insu-
lin sensitivity, The population at risk was stratified accord-
ing to fasting plasma glucose to evaluate the VO2max
correlation from normal to impaired glucose regulation in
three groups: Fasting plasma glucose (FPG) under 100
mg/dl, FPG = 101-109, FPG> = 110.
Results
1769 people completed and returned the CDPP risk
assessment tool to join "at risk registry", of whom, 1423
had at least one positive risk factor (excluding sedentary
lifestyle or ethnicity as the only risk factor). Of the 466
who signed the informed consent to participate in the
project 28 dropped voluntarily before completing base-
line screening, diabetes was discovered and diagnosed in
14 individuals and 8 were found to have the full IRS, the
remaining 418 at risk non insulin resistant individuals
were followed for 5 years. Table 2 represents the popula-
tion stratified according to ADA criteria for impaired fast-
ing plasma glucose, considering FPG under 100 mg/dl,
FPG = 101 to 109 and FPG> = 110. There was no signifi-
cant difference in VO2max between these groups. The
analysis was limited to the 369 subjects with fasting
plasma glucose under 110 mg/dl, following WHO criteria
to exclude impaired glucose regulation.
The results of physical and laboratory assessment are
shown in table 3. Table 4 lists the prevalence of risk factors
in this population. VO2max was the most prevalent
abnormality in this population of individuals who were at
risk for type 2 diabetes but who did not have IRS or T2DM
at baseline. VO2max had an inverse correlation with
HOMA-IR(r = -0.30, p < 0.0001), showing that increased
insulin resistance is associated with decreased VO2max.
96% of individuals at risk for type 2 diabetes had VO2
max results under health range for their age and sex of
whom 11% were in moderate risk and 85% were in high
risk for developing disease related with low aerobic capac-
ity (diabetes, stroke, coronary disease and some forms of
cancer) (24).
The control group had a VO2max = 26 ± 9 ml/kg/min 15%
higher than CDPP population (p < 0.001). Cardiorespira-
tory fitness was considered healthy in 14% of control
group, compared with only 4% of CDPP group (x2 = 11.4
p < 0.001) shown at table 5.
Discussion
In a population at high risk for IRS and T2DM, individuals
were enrolled at an earlier stage in the progression of dis-
ease when compared with other prevention studies.
Importantly, low exercise capacity or cardiorespiratory fit-
ness (VO2max) was the most prevalent abnormality at
baseline assessment for this population. When compared
a control group with similar anthropometric measures, as
well as low level of physical activity, both groups had
marked low maximal oxygen consumption however, on
average VO2max was 15% higher in the control subjects.
This finding is in line with several recent studies that
showed significant association between insulin resistance
and low physical fitness in nondiabetic subjects [15,16].
Table 2: Stratification VO2max value and Fasting Plasma 
Glucose levels 
VO2 max (ml/kg/min)
FPG (mg/dl) Means* N SD
<100 22,28 246 6,02
100-109 21,29 121 5,97
> = 110 20,18 49 6,28
All Groups 21,74 416 6,06
*p-value = 0.054
Table 3: Results of physical and laboratory evaluation of CDPP 
group (n = 369)
Variables Results (mean ± SD)
BMI (kg/m2) 28.8 ± 6.3
Cholesterol (mg/dl) 206 ± 38.5
LDL-C (mg/dl) 128 ± 33
HDL-C (mg/dl) 49 ± 15
Triglycerides (mg/dl) 154 ± 90
Fasting Glucose (mg/dl) 96 ± 6.7
Systolic BP/Diastolic BP (mm/Hg) 125 ± 14.5/80 ± 8.4
Waist/Hip Ratio - Fem 0.81 ± 7
Waist/Hip Ratio - Male 0.92 ± 6
VO2max (ml/kg/min) 21.9 ± 6
Insulin (μU/ml) 7.2 ± 5.1
C-Peptideo (ng/ml) 2.4 ± 2.0
HbA1c (%) 5.4 ± 0.5
HOMA score 1.51 ± 1.13Page 3 of 6
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fitness have been associated with increased risk for T2DM
[17-19].
Individuals with type 2 diabetes, have previously been
shown to have 20% lower cardiorespiratory fitness
(VO2max) compared to control subjects [20]. People at
risk may progressively decrease aerobic capacity in the
natural history of the development of insulin resistance
syndrome and T2DM.
Wei et al [21] found that low cardiorespiratory fitness is
significantly associated with impaired fasting glucose and
type 2 diabetes, as well as independent predictor of all-
cause mortality in men with T2DM [22].
Eriksson and Lindgarde showed a progressive decrease at
VO2max as glucose regulation declines from normal to
IGT and T2DM [23]. With respect to this progression,
individuals in our population fell in the normal to IGT
range for blood glucose, while the majority (84%) had
Table 4: Prevalence of risk factors in this population.
Measure Value % Subjects
(N = 369)
FBG > = 100 41%
SBP > = 130 38%
DBP > = 85 28%
Cholesterol > = 200 59%
LDL > = 130
> = 100
46%
79%
HDL M<40, F<50 53%
Triglycerides >150 42%
BMI > = 30 34%
A1C >5.8 9%
Fasting Insulin >23 3%
C-peptide >4.0 7%
WHR M> = 1.00 or F> = 0.85 24%
VO2 Max based on age and gender High Risk
M<33, F<26
Moderate to High Risk
84%
96%
Positive Family History 70%
Table 5: CDPP and External Control Group Comparison
Group Healthy
VO2max(ml/kg/min)
M>38; F>30
Moderate Risk
VO2max(ml/kg/min)
M = 33-38; F = 26-30
High Risk VO2max(ml/kg/min)
M<33; F<26
Control 14% 13% 73%
CDPP 4% 12% 84%
X2 = 11.4 (p < 0.001)Page 4 of 6
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decreased insulin sensitivity.
An early step in the development of insulin resistance in
offspring of patients with type 2 diabetes is impaired
mitochondrial activity [24]. Kaplan et al [25] concluded
that insulin plays an important role in the regulation of
mitochondrial anion transporter function during the
Krebs cycle Oxygen consumption for oxidation of Acetyl-
CoA produced by glycolysis.
This abnormality could be the earlier impairment of insu-
lin sensitivity in the study population, since 70% of them
had family history of diabetes. Low number of mitochon-
dria, genetically determined, explains the altered con-
sumption of glucose and oxygen which may impact an
individual's ability to achieve an acceptable fitness level
and consequently have low VO2max.
Our study has limitations. The cross-section design does
not allow establishing cause-effect relationship. Also,
HOMA IR is not an ideal way to measure insulin resist-
ance and we have not calculated the control group's
HOMA IR index. In spite of that, the low HOMA IR level
in the study population showed that they were not insulin
resistant yet. However, they had already presented mark-
edly low VO2max, which is related to endothelium dys-
function. This raises the possibility that decreased VO2
max is among the earliest indicators of IRS and T2DM
therefore, an important risk factor for disease progression.
Previous studies have suggested that higher levels of regu-
lar physical activity and cardiorespiratory fitness
(VO2max) are associated with a reduced risk of coronary
heart disease [26,27]. Low physical fitness has been asso-
ciated with increased clustering of the metabolic abnor-
malities associated with the metabolic syndrome [28,29].
Ferreira et al found that VO2max was inversely associated
with arterial stiffness, and this was independent of the
metabolic syndrome [30].
Physical activity levels are currently overestimated partic-
ularly in the obese population. The finding of decreased
VO2max as an early marker for IRS/T2DM may encourage
people at risk to participate in regular physical activity and
improve cardiorespiratory fitness in order to prevent insu-
lin resistance, type 2 diabetes and atherosclerosis acceler-
ation.
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